3D Tissue Models

View Profile

Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors Review type Summary Keywords File filename File mime type
1. 2009 Baseline utilization of breast radiotherapy prior to Institution of the Medicare Practice Quality Reporting Initiative. Int J Radiat Oncol Biol Phys. e-Pub 4/2009.
2. 2009 Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. Int J Radiat Oncol Biol Phys 73(3):944-51, 3/2009
3. 2009 The impact of pregnancy on breast cancer outcomes in women </=35 years Cancer 115(6):1174-84, 3/2009.
4. 2009 Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Cancer 115(8):1605-12, 2/2009. e-Pub 2/5/2009.
5. 2009 Effects of variable placement of superior tangential/supraclavicular match line on dosimetric coverage of level III axilla/axillary apex in patients treated with breast and supraclavicular radiotherapy. Int J Radiat Oncol Biol Phys 73(2):370-4, 2/2009.
6. 2009 Radiation therapy in the management of early-stage breast cancer after breast-conserving surgery Buchholz TA
7. 2009 Effects of natural polyphenols on chemoradiotherapy in cancer. In: Herbal Drugs: A Cancer Chemopreventive and Therapeutic Perspective. Chapter 22, 1-22, 2009.
8. 2009 The Breast. In: Radiation Oncology, 9th. Elsevier: Philadelphia, PA. In Press.
9. 2009 Breast-Conserving Therapy: Conventional Whole Breast Irradiation. In: Diseases of the Breast, 4th. Lippincott Williams Wilkins: Baltimore, MD, 507-521, 2009.
10. 2009 Radiation Therapy in Breast-Conserving Therapy. In: Principles and Practices of Radiation Oncology, 6th. Lippincott Williams & Wilkins: Baltimore, MD. In Press.
11. 2009 Whole Breast Radiotherapy. In: Breast Surgery Book Ed(s) Scott-Conner, Dirbas. Spring-Verlag: Germany. In Press.
12. 2009 Principles of radiation oncology in the older adult. In: Practical Geriatric Oncology. Cambridge University Press. In Press.
13. 2009 Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol. e-Pub 4/29/2009.
14. 2009 Quantifying Tumor-Selective Radiation Dose Enhancements Using Gold Nanoparticles: A Monte Carlo Simulation Study. Biomed Microdevices. e-Pub 4/21/2009
15. 2009 Racial disparities in treatment for early invasive breast cancer: a national Medicare study of radiotherapy after conservative surgery Cancer. In Press.
16. 2009 The lateral decubitus breast boost: description, rationale and efficacy. Int J Radiat Oncol Biol Phys. e-Pub 4/23/2009.
17. 2009 Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort Int J Radiat Oncol Biol Phys. In Press.
18. 2009 DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early onset breast cancer. PLoS Medicine. In Press.
19. 2009 Coexpression of {alpha}6{beta}4 Integrin and Guanine Nucleotide Exchange Factor Net1 Identifies Node-Positive Breast Cancer Patients at High Risk for Distant Metastasis. Cancer Epidemiol Biomarkers Prev 18(1):80-6, 1/2009.
20. 2009 Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: in cadence and local controls. Int J Radiat Oncol Biol Pys. In Press.
21. 2009 Breast conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg. In Press.
22. 2009 Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO J Am Coll Surg. In Press
23. 2009 Breast Cancer Regional Radiation Fields for Supraclavicular and Axillary Lymph Node Treatment: Is a Posterior Axillary Boost Field Technique Optimal? Int J Radiat Oncol Biol Phys 74(1). e-Pub 9/2009.
24. 2009 Accelerated partial breast irradiation consensus statement from the American Society for radiation Oncology (ASTRO Int J Radiat Oncol Biol Phys 74:987-1001, 6/2009.
25. 2009 Even Low-level HER2 Expression May be Associated With Worse Outcome in Node-positive Breast Cancer. Am J Surg Pathol 33(5):759-67, 5/2009. e-Pub 2/2009.
26. 2009 Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a two-year follow-up study. J Clin Oncol 27(12):2007-2014, 4/2009. e-Pub 3/16/2009.
27. 2009 Hypothyroidism in older patients with head and neck cancer after treatment with radiation: a population-based study. Head Neck. e-Pub 4/2009
28. 2008 Prognostic value of initial clinical disease stage after achieving pathological complete response. Oncologist 13(1):6-15, 1/2008.
29. 2008 Treatment of ductal carcinoma in situ. In: Advanced Therapy in Surgical Oncology. Ed(s) BC Decker Inc.: Hamilton, Ontario, 482-488, 2008.
30. 2008 Radiation therapy for locally advanced breast cancer The Breast, 4th. Elsevier, 2008.
31. 2008 Locally advanced breast cancer. In: Handbook of Radiation Oncology Jones and Bartlett Publishers, Inc.: Sudbury, MA, 441-462, 2008.
32. 2008 Early stage breast cancer. In: Principles and Practice of Radiation Oncology, 5th. Lippincott Williams & Wilkins: Baltimore, MD, 1175-1291, 2008.
33. 2008 cancer: locally advanced and recurrent disease; postmastectomy radiation; systemic therapies. In: Principles and Practice of Radiation Oncology, 5th. Lippincott Williams & Wilkins: Baltimore, MD, 1292-1317, 2008
34. 2008 Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes. J Clin Oncol 27(2). e-Pub 12/2008.
35. 2008 Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer Clin Cancer Res 14(23):7909-7916, 12/2008.
36. 2008 Development of a successful outreach program at M. D. Anderson Cancer Center: a global perspective. J Am Coll Radiol 5(12):1170-1173, 12/2008.
37. 2008 A management algorithm and practical oncoplastic surgical techniques to repair partial mastectomy defects Plat Reconstr Surg 122(6):1631-1647, 12/2008.
38. 2008 Dose to the Contralateral Breast from Radiotherapy and Risk of Second Primary Breast Cancer in the WECARE Study. Int J Radiat Oncol Biol Phys 72(4):1021-1030, 11/2008. e-Pub 6/14/2008.
39. 2008 The radiation exposure from portal images during the course of breast radiotherapy Am J Clin Oncol 31(4):345-351, 8/2008
40. 2008 Staging of breast cancer in the neoadjuvant setting. Cancer Res 68(16):6477-6481, 8/2008.
41. 2008 Risk of subclinical micrometastatic disease in the supraclavicular nodal bed based on the anatomical distribution in patients with advanced breast cancer. Int J Radiat Oncol Biol Phys 71(2):435-440, 6/2008
42. 2008 Use of post-mastectomy radiotherapy in older women. Int J Radiat Oncol Biol Phys 71(1):98-106, 5/2008.
43. 2008 Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome. Int J Radiat Oncol Biol Phys 71(1):226-236, 5/2008.
44. 2008 Statement of the science concerning loco-regional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute Conference. J Clin Oncol 26(5):791-797, 2/2008.
45. 2008 Local-regional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys 72(2):474-84, 10/1/2008. e-Pub 4/2008.
46. 2008 Automatic Segmentation of Whole Breast Using Atlas Approach and Deformable Image Registration Int J Radiat Oncol Biol Phys 73(5):1493-500, 9/17/2008. e-Pub 9/17/2008.
47. 2008 Ten year recurrence rates in young women with breast cancer by locoregional treatment approach. Int J Radiat Oncol Biol Phys 73(3):734-44, 8/14/2008. e-Pub 8/2008.
48. 2008 Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol 26(31):5119-25, 8/25/2008. e-Pub 8/25/2008.
49. 2008 Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and 1-3 positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 71(4):1022-7, 7/15/2008.
50. 2008 Completion of adjuvant radiation therapy among women with breast cancer Cancer 113(1):22-9, 7/1/2008. e-Pub 4/2008.
51. 2008 Prognostic significance of HER2 status in women with inflammatory breast cancer. Cancer 112(9):1905-11, 5/1/2008. e-Pub 2/2008.
52. 2008 Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer 112(6):1371-1379, 3/2008.
53. 2007 Inflammatory breast cancer (IBC) and patterns of recurrence: Understanding the biology of a unique disease Cancer 110(7):1436-1444, 10/2007.
54. 2007 Practical guidelines for the breast reduction technique for repair of partial mastectomy defects in patients undergoing breast conservation therapy Plastic Reconstructive Surg 120(7):1755-1768, 12/2007.
55. 2007 Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer. Int J Radiat Oncol Biol Phys 69(3):711-715, 11/2007.
56. 2007 Prospective analysis of carotid flow in breast cancer patients treated with supraclavicular irradiation eight or more years prior to study: No increase in ipsilateral carotid stenosis after radiation Cancer 112(2):268-273, 11/2007.
57. 2007 Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110(11):2420-2427, 11/2007. e-Pub 10/2007.
58. 2007 Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 194(4):527-531, 10/2007.
59. 2007 Genetic variants in the promoter region of H2AX are associated with risk of sporadic breast cancer in non-Hispanic white women 55 years. Breast Cancer Res Treat 110(2):357-66, 9/2007.
60. 2007 Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy. Int J Rad Oncol Biol Phys 69:1478-1483, 9/2007.
61. 2007 Trends for inflammatory breast cancer: Is survival improving? Oncologist 12(8):904-912, 8/2007.
62. 2007 Low local-regional failure rates in selected breast cancer patients with tumor-positive sentinel nodes who do not undergo completion axillary dissection. Cancer 110(4):723-730, 8/2007.
63. 2007 Post-mastectomy radiation improves the outcome of patients with stage III breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy Int J Radiat Oncol Biol Phys 68(4):1004-1009, 7/2007.
64. 2007 The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: An analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 68(1):59-65, 5/2007.
65. 2007 Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in ER-positive breast cancers. Ann Oncol 18(5):874-880, 5/2007. e-Pub 2/2007.
66. 2007 Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: A phantom model comparison Radiother Oncol 82(3):324-328, 3/2007.
67. 2007 130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain. Clin Cancer Res 13(6):1868-1874, 3/2007.
68. 2007 Wnt/(beta)-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line J Cell Sci 120(3):468-477, 2/2007.
69. 2007 Local-regional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Rad Oncol Biol Phys 67(2):490-496, 2/2007.
70. 2007 Wnt/B-catenin-mediated radiation resistance of mouse mammary stem-like/progenitor cells. Proc Nat Acad Sciences 104(2):618-623, 1/2007.
71. 2007 Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen. Clin Cancer Res 13(1):228-33, 1/2007.
72. 2007 Intraoperative margin assessment for breast-conserving surgery. Ann Surg Oncol 14(4):1458-1471, 1/2007. e-Pub 1/2007.
73. 2007 Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Radiat Oncol Biol Phys 67(2):490-6, 2/1/2007.
74. 2007 Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clin Oncol 26(2):246-252, 1/2008. e-Pub 12/2007.
75. 2006 Comparison of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Rad Oncol Biol Phys 66:352-7, 2006.
76. 2006 Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke Cancer 106:2556-62, 6/2006.
77. 2006 The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"? Int J Radiat Oncol Biol Phys 65(5):1345-52, 5/2006.
78. 2006 High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy. Bone Marrow Transplant 37:929-35, 5/2006.
79. 2006 Integration of systemic treatments and radiation in breast cancer. In: Multimodality Concepts for Integration of Cytoxic Drugs and Radiation Therapy. Ed(s) Brown JM, Mehta MP, Nieder C. Springer-Verlag: Heidelberg, Germany, 251-265, 2006.
80. 2006 African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy Cancer 107(11):2662-2668, 12/2006.
81. 2006 Breast Cancer. In: Levitt and Tapley's Technological Basis of Radiation Therapy, 4th. Ed(s) Levitt SH. Springer-Verlag: Heidelberg, Germany, 485-510, 2006.
82. 2006 The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers J Clin Oncol 24:361-9, 1/2006.
83. 2006 Biphasic metaplastic sarcomatoid carcinoma of the breast Ann Oncol 17:605-13, 4/2006.
84. 2006 Accelerated partial breast irradiation (APBI): history, rationale, controversies. In: Accelerated Partial Breast Irradiation. Ed(s) Wazer DE, Arthur DW, Vicini FA. Springer-Verlag: Heidelberg, Germany, 1-15, 2006.
85. 2006 The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 66(1):76-82, 6/2006.
86. 2006 Breast cancer stages T3 and T4: Locally advanced and inflammatory breast cancer and postmastectomy radiation therapy. In: Clinical Radiation Oncology, 2nd. Ed(s) Gunderson LL, Tepper JE. Churchill Livingstone/Elservier: Philadelphia, PA, 1503-1518, 2006.
87. 2006 Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer Am Coll Surg 203:64-72, 7/2006.
88. 2006 Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy J Clin Oncol 24:4971-5, 11/2006.
89. 2006 Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer. Int J Radiat Oncol Biol Phys 65:1155-60, 5/2006
90. 2006 Risk of in situ or invasive relapse and mastectomy in older women with ductal carcinoma in situ. J Nat Cancer Inst 98:1302-10, 2006.
91. 2006 Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors J Clin Oncol 24:1037-44, 2006.
92. 2006 Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer 107:1348-54, 2006.
93. 2006 Outcomes of breast conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma Am J Surg 192:552-5, 2006.
94. 2006 Low local recurrence rate without post-mastectomy radiation in node-negative breast cancer patients with tumors 5cm and larger Int J Rad Oncol Biol Phys 66:358-64, 2006.
95. 2006 . Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy Cancer 106:42-50, 2006.
96. 2006 Dose modification factors for 192lr high-dose-rate irradiation using Monte Carlo simulations J Appl Clin Med Phys 7(3):28-34, 2006.
97. 2005 Squamous cell carcinoma of the breast. J Clin Oncol 23:7827-35, 11/2005.
98. 2005 Breast conservation after neoadjuvant chemotherapy Cancer 103:689-95, 2/2005.
99. 2005 Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97:419-24, 3/2005.
100. 2005 Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry Cancer 103:1581-6, 4/2005.
101. 2005 Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma Cancer 103:1323-9, 4/2005.
102. 2005 Paget's disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol 12:391-7, 5/2005.
103. 2005 Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci U S A 102:8315-20, 6/2005.
104. 2005 Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 62:351-7, 6/2005.
105. 2005 Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer J Clin Oncol 23(16):3676-85, 6/2005.
106. 2005 Improving local control with breast-conserving therapy: a 27-year single-institution experience Cancer 104:20-9, 7/2005.
107. 2005 Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 23:41-48, 7/2005.
108. 2005 Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy. Cancer 104:676-81, 8/2005.
109. 2005 Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence Cancer 104:479-90, 8/2005.
110. 2005 Cardiac morbidity of adjuvant radiotherapy for breast cancer J Clin Oncol 23:7475-82, 10/2005.
111. 2005 Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy J Clin Oncol 23:7098-104, 10/2005.
112. 2005 Immediate breast reconstruction can impact postmastectomy irradiation Am J Clin Oncol 28:485-494, 10/2005.
113. 2005 Metaplastic sarcomatoid carcinoma of the breast with absent or minimal overt invasive carcinomatous component: a misnomer. Am J Surg Pathol 29:1456-63, 11/2005.
114. 2005 Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy Int J Radiat Oncol Biol Phys 63:1508-13, 12/2005.
115. 2005 . The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer. Clin Cancer Res 11:8398-402, 12/2005.
116. 2005 Neoplasms of the breast. In: Cancer Medicine, 7th. Ed(s) Kufe, Bast, Hait, Hong, Pollock, Weichselbaum, Hollnad, Frei. BC Decker: Hamilton, Ontario, 1879-1970, 2005.
117. 2004 Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience J Clin Oncol 22:2303-12, 6/2004.
118. 2004 T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy Int J Radiat Oncol Biol Phys 59:138-45, 5/2004.
119. 2004 Locally advanced breast cancer. In: Advanced Therapy of Breast Disease, 2nd: Hamilton, Ontario, 498-508, 2004
120. 2004 Breast cancer. In: Practical Essential of Intensity Modulated Radiation Therapy, 2nd. Lippincott: Philadelphia, 238-254, 2004.
121. 2004 Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol 11:854-60, 9/2004.
122. 2004 Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 59:1337-42, 8/2004.
123. 2004 Radiosensitivity is predicted by DNA end-binding complex density, but not by nuclear levels of band components Radiother Oncol 72:325-32, 9/2004.
124. 2004 Delayed-immediate breast reconstruction Plast Reconstr Surg 113:1617-28, 5/2004.
125. 2004 The role of radiation in the treatment of ductal carcinoma of the breast. In: Advanced Therapy of Breast Disease 2nd: Hamilton, Ontario, 314-320, 2004.
126. 2004 Consensus Conference Committee. Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast Breast J 10:273-294, 4/2004.
127. 2004 The biologic rationale for and emerging role of accelerated partial breast irradiation for breast cancer J Am Coll Surg 199:479-92, 9/2004.
128. 2004 Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. J Natl Cancer Inst 96:1676-81, 11/2004.
129. 2004 Fertility in men after treatment for stage 1 and 2A seminoma. Am J Clin Oncol 27:584-8, 12/2004.
130. 2004 Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy J Clin Oncol 22:4691-9, 12/2004.
131. 2004 A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls Cancer 100:1345-51, 4/2004.
132. 2004 Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. Cancer 100:942-9, 3/2004.
133. 2004 Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction Am J Surg 187:164-9, 2/2004.
134. 2004 Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma Cancer 100:499-506, 2/2004.
135. 2004 Consensus Conference Committee. Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast Cancer 100:2512-2532, 2/2004.
136. 2004 Predicting radiosensitivity using DNA end-binding complex analysis. Clin Cancer Res 10:1226-34, 2/2004.
137. 2004 Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer 100:490-8, 2/2004.
138. 2004 Advances in radiation treatments of breast cancer Clin Breast Cancer 4(6):401-6, 2/2004.
139. 2004 Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. Int J Radiat Oncol Biol Phys 59:1074-9, 7/2004.
140. 2004 Accumulation of the common mitochondrial DNA deletion induced by ionizing radiation. FEBS Lett 571:227-32, 7/2004.
141. 2003 . Automated quantification of apoptosis after neoadjuvant chemotherapy for breast cancer: early assessment predicts clinical response. Clin Cancer Res 9(3):955-60, 3/2003.
142. 2003 The Breast. In: Radiation Oncology, 8th. Mosby: St Louis, 333-387, 2003.
143. 2003 Neoplasms of the breast. In: Cancer Medicine, 6th. BC Decker: Hamilton, Ontario, 1879-1970, 2003.
144. 2003 Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy Cancer J 9(1):33-41
145. 2003 Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys 57(2):336-44, 10/2003.
146. 2003 Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int J Radiat Oncol Biol Phys 57(2):327-35, 10/2003.
147. 2003 Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: implications for post-mastectomy radiation therapy Int J Radiat Oncol Biol Phys 57(1):128-35, 9/2003.
148. 2003 Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks Cancer 98(6):1150-60, 9/2003.
149. 2003 Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol 21(17):3244-8, 9/2003.
150. 2003 Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors Clin Cancer Res 9(7):2406-15, 7/2003.
151. 2003 Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol 10(6):628-34, 7/2003.
152. 2003 Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma. Cancer 97(12):2960-71, 6/2003.
153. 2003 Molecular profiles of invasive mucinous and ductal carcinomas of the breast: a molecular case study. Cancer Genet Cytogenet 141(2):148-53, 3/2003.
154. 2003 Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97(4):926-33, 2/2003.
155. 2002 Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95(10):2059-67, 11/2002.
156. 2002 Breast-conservation therapy in early-stage breast cancer patients with a positive family history. Ann Surg Oncol 9(9):912-9, 11/2002.
157. 2002 Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: The University of Texas M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 54(3):804-9, 11/2002.
158. 2002 Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. Int J Radiat Oncol Biol Phys 53(5):1225-33, 8/2002.
159. 2002 Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy Int J Radiat Oncol Biol Phys 53(4):880-8, 7/2002.
160. 2002 Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9(6):543-9, 7/2002.
161. 2002 Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma. Cancer 94(12):3107-14, 6/2002.
162. 2002 Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 9(3):256-65, 4/2002.
163. 2002 A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast conservation therapy feasibility. Ann Surg Oncol 9:228-234, 4/2002.
164. 2002 Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2 Int J Cancer 97(5):557-61, 2/2002.
165. 2002 Cyclin E and survival in patients with breast cancer N Engl J Med 347(20):1566-75, 11/2002.
166. 2002 Global gene expression changes during neoadjuvant chemotherapy for human breast cancer Cancer J 8(6):461-8, 11/2002.
167. 2002 Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg 194(1):54-64, 2002.
168. 2002 Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation J Clin Oncol 20(1):17-23, 2002.
169. 2002 Application of DNA microarray technology to clinical biopsies of breast cancer. In: Computational And Statistical Approaches To Genomics Kulwer Press, 257-275, 2002.
170. 2001 Breast conservation therapy as a treatment option for the elderly. The M. D. Anderson experience. Cancer 92(5):1092-100, 9/2001.
171. 2001 Verification of tangential breast treatment dose calculations in a commercial 3D treatment planning system. J Appl Clin Med Phys 2(2):73-84, 12/2001.
172. 2001 Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg 182(6):601-8, 12/2001.
173. 2001 Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation Int J Radiat Oncol Biol Phys 51(3):671-8, 11/2001.
174. 2001 A custom three-dimensional electron bolus technique for optimization of postmastectomy irradiation Int J Radiat Oncol Biol Phys 51(4):1142-51, 11/2001.
175. 2001 Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy. Cancer J 7(5):413-20, 9/2001.
176. 2001 The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 50(3):735-42, 7/2001.
177. 2001 Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation. Int J Radiat Oncol Biol Phys 50(2):397-403, 6/2001.
178. 2001 Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases Ann Surg Oncol 8(5):425-31, 6/2001.
179. 2001 A case-control study of unilateral and bilateral breast carcinoma patients. Cancer 91(10):1845-53, 5/2001.
180. 2001 Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol 19(8):2240-6, 4/2001.
181. 2001 Radiation-induced chromatid breaks as a predictor of breast cancer risk Int J Radiat Oncol Biol Phys 49(2):533-7, 2/2001.
182. 2001 Coronary artery dosimetry in intact left breast irradiation. Cancer J 7(6):492-7, 11/2001.
183. 2000 Gamma-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report Int J Oncol 17(2):399-404, 8/2000.
184. 2000 Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant Int J Radiat Oncol Biol Phys 46(2):337-43, 1/2000.
185. 2000 Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 18(15):2817-27, 8/2000.
186. 2000 Presentation, management and outcome of axillary recurrence from breast cancer. Am J Surg 180:252-256, 8/2000.
187. 2000 Ductal carcinoma-in-situ: long-term results of breast-conserving therapy Ann Surg Oncol 7(9):656-64, 10/2000.
188. 2000 Local-regional control in breast cancer patients with a possible genetic predisposition. Int J Radiat Oncol Biol Phys 48(4):951-7, 11/2000.
189. 2000 Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium Am J Hum Genet 67(6):1437-51, 12/2000.
190. 2000 Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer Ann Surg Oncol 7(6):435-40, 7/2000.
191. 1999 TP53 overexpression in radiation-induced osteosarcoma of the rabbit mandible. Radiat Res 151(3):278-82, 3/1999.
192. 1999 Do calcium channel blockers adversely affect hormonal therapy of prostate cancer through an inhibition of apoptosis? Prostate J 1(1):43-48, 2/1999.
193. 1999 Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy J Clin Oncol 17(2):460-9, 2/1999.
194. 1999 A comparison of 18-MV and 6-MV treatment plans using 3D dose calculation with and without heterogeneity correction Med Dosim 24(4):287-94, 2/1999.
195. 1999 Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer. Ann Surg Oncol 6(1):102-8, 1999.
196. 1999 Tamoxifen-induced thrombocytopenia. Am J Clin Oncol 22(5):529-32, 10/1999.
197. 1999 Frequency of first metastatic events in breast cancer: implications for sequencing of systemic and local-regional treatment J Clin Oncol 17(9):2649-58, 9/1999.
198. 1999 Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. Cancer J Sci Am 5(3):159-64, 5/1999.
199. 1999 Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control? Int J Radiat Oncol Biol Phys 44(1):105-12, 4/1999.
200. 1999 Tumor suppressor genes and breast cancer. Radiat Oncol Investig 7(2):55-65, 3/1999.
201. 1998 Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg 176(6):502-9, 12/1998
202. 1998 Radiation therapy and chemotherapy for thoracic spine metastases. In: The Thoracic Spine Medical Publishing Inc.: St. Louis, 412-432, 1998.
203. 1998 Breast cancer. In: Levitt and Tapleys Technological Basis of Radiation Therapy: Clinical Applications, 3rd. Lippincott Williams & Wilkins: Baltimore, 301-313, 1998.
204. 1998 A survey of current clinical practice of permanent prostate brachytherapy in the United States Int J Radiat Oncol Biol Phys 40(2):461-5, 1/1998.
205. 1998 Cost-effectiveness of posttreatment surveillance after radiation therapy for early stage seminoma. Cancer 82(6):1126-33, 3/1998.
206. 1998 Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status. Cancer J Sci Am 4(4):230-6, 7/1998.
207. 1998 Isoseparation curves: a mechanism for optimizing off-axis dose homogeneity of intact breast irradiation. Radiat Oncol Investig 6(4):191-8, 3/1998.
208. 1997 Dosimetric analysis of intact breast irradiation in off-axis planes Int J Radiat Oncol Biol Phys 39:261-7, 8/1997
209. 1997 Boron neutron capture enhanced fast neutron radiotherapy for malignant gliomas and other tumors. J Neuro Oncol 33:171-8, 5/1997.
210. 1997 Breast cancer. In: OncoSource. Varian Corporation: Palo Alto
211. 1996 BNCT as an adjuvant to fast neutron radiotherapy for selected tumor systems. In: Cancer Neutron Therapy Plenum Press: New York, 777-782, 1996
212. 1994 Metastatic lymphoma and spinal cord compression. In: Practical Approaches to Cancer Invasion and Metastases. Springer-Verlag: Berlin, 58-64, 1994
213. 1994 Concomitant boron-neutron capture therapy during fast-neutron irradiation of a rat glioma. Radiology 191(3):863-7, 6/1994.
214. 1994 Boron neutron capture therapy: a mechanism for achieving a concomitant tumor boost in fast neutron radiotherapy Int J Radiat Oncol Biol Phys 28(5):1135-42, 3/1994
215. 1994 Fast neutron radiotherapy. The University of Washington experience. Acta Oncol 33(3):275-80, 6/1994.
216. 1994 Enhancement of fast neutron beams with boron neutron capture therapy. A mechanism for achieving a selective, concomitant tumor boost Acta Oncol 33(3):307-13, 6/1994.
217. 1993 Effect of delay in radiation in the combined modality treatment of breast cancer Int J Radiat Oncol Biol Phys 26(1):23-35, 4/1993.
218. 1993 Neutron radiotherapy for adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 119(7):747-52, 7/1993.
219. 1992 The role of fast neutron radiation therapy in the management of advanced salivary gland malignant neoplasms. Cancer 69:2779-88, 6/1992.
220. 1992 Neutron beam radiotherapy for head and neck cancer. In: Controversies in Oral and Maxillofacial Surgery. W.B. Saunders Co., 616-663, 1992
221. 1992 Fast neutron radiation for recurrent pleomorphic adenomas of the parotid gland. Am J Clin Oncol 15(5):441-5, 10/1992.
222. 1990 Treatment of adenoid cystic carcinoma of the salivary gland, a three-field technique Med Dosim 15:99-105, 3/1990

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.